pituitrin and Histiocytosis--Non-Langerhans-Cell

pituitrin has been researched along with Histiocytosis--Non-Langerhans-Cell* in 1 studies

Other Studies

1 other study(ies) available for pituitrin and Histiocytosis--Non-Langerhans-Cell

Article	Year
Syndrome of inappropriate secretion of antidiuretic hormone in patients with lymphoma-associated hemophagocytic syndrome. Annals of hematology, 1995, Volume: 70, Issue:1 We report three lymphoma patients in whom the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) was observed during the course of lymphoma-associated hemophagocytic syndrome (LAHS). The clinical course was devoid of any known mechanism for SIADH which could be attributable to lymphoma or antineoplastic treatment. Alternatively, high serum levels of interleukin-1 beta and tumor necrosis factor-alpha, which stimulate the secretion of antidiuretic hormone, may have contributed to the development of SIADH in our patients, who were receiving glucocorticoids. In conclusion, LAHS patients should be considered to be at high risk for SIADH. Topics: Aged; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Inappropriate ADH Syndrome; Interleukin-1; Lymphoma; Lymphoma, T-Cell; Male; Middle Aged; Nose Neoplasms; Risk Factors; Sodium; Tumor Necrosis Factor-alpha; Vasopressins	1995

Article

Year

Syndrome of inappropriate secretion of antidiuretic hormone in patients with lymphoma-associated hemophagocytic syndrome.

Annals of hematology, 1995, Volume: 70, Issue:1

We report three lymphoma patients in whom the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) was observed during the course of lymphoma-associated hemophagocytic syndrome (LAHS). The clinical course was devoid of any known mechanism for SIADH which could be attributable to lymphoma or antineoplastic treatment. Alternatively, high serum levels of interleukin-1 beta and tumor necrosis factor-alpha, which stimulate the secretion of antidiuretic hormone, may have contributed to the development of SIADH in our patients, who were receiving glucocorticoids. In conclusion, LAHS patients should be considered to be at high risk for SIADH.

Topics: Aged; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Inappropriate ADH Syndrome; Interleukin-1; Lymphoma; Lymphoma, T-Cell; Male; Middle Aged; Nose Neoplasms; Risk Factors; Sodium; Tumor Necrosis Factor-alpha; Vasopressins

1995